Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma

BJU International

Volumn 102, Issue 6, 2008, Pages 747-755

  Guerrero, David ^a,b   Guarch, Rosa ^b   Ojer, Amaya ^b   Casas, Juan Manuel ^b   Ropero, Santiago ^c   Mancha, Ana ^b   Pesce, Carlo ^d   Lloveras, Belen ^e   Garcia Bragado, Federico ^b   Puras, Ana ^b  

^a Biomedical Research Center   (Spain)

^b Universidad Pública de Navarra

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d UNIVERSITY OF GENOA   (Italy)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Hypermethylation; p16; Penile squamous cell carcinoma; RASSF1 A; Survival; Thrombospondin 1

Indexed keywords

CD31 ANTIGEN; FLUOROURACIL; PROTEIN P16; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; THROMBOSPONDIN 1;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION; PATHOGENESIS; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PENILE NEOPLASMS; PROGNOSIS; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; THROMBOSPONDIN 1; TUMOR SUPPRESSOR PROTEINS;

EID: 50049121830     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07603.x     Document Type: Article

References (51)

1. Kayes O, Ahmed HU, Arya M, Minhas S. Molecular and genetic pathways in penile cancer. Lancet Oncol 2007 8 : 420 9
2. Carter JJ, Porter PL, Galloway DA et al. eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004
3. Daling JR, Madeleine MM, Johnson LG et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005 10 : 606 16
4. Levi JE, Rahal P, Sarkis AS, Villa L. Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 1998 76 : 779 83
5. Lont AP, Gallee MP, Meinhardt W, van Tinteren H, Horenblas S. Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol 2006 176 : 575 80
6. Hegarty PK, Kayes O, Freeman A, Christopher N, Ralph DJ, Minhas S. A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. BJU Int 2006 98 : 526 31
7. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001 107 : 929 34
8. Ren B, Yee KO, Lawler J, Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 2006 1765 : 178 88
9. Gietema JA, Hoekstra R, de Vos FY et al. A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors. Ann Oncol 2006 17 : 1320 7
10. Wang TN, Qian X, Granick MS et al. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J Surg Res 1996 63 : 39 43
11. Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005 65 : 3497 508
12. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998 16 : 1197 206
13. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005 45 : 629 56
14. Li Q, Ahuja N, Burger PC, Issa JP. Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene 1999 18 : 3284 9
15. Dammann R, Schagdarsurengin U, Seidel C et al. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 2005 20 : 645 63
16. Kang S, Kim JW, Kang GH et al. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 2006 118 : 2168 71
17. Dhawan D, Hamdy FC, Rehman I et al. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. J Pathol 2006 209 : 336 43
18. Esteller M, Herman JG. Cancer as an epigenetic disease. DNA methylation and chromatin alterations in human tumors. J Pathol 2002 196 : 1 7
19. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001 7 : 584 9
20. Nuovo GJ, Plaia TW, Belinsky SA, Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999 96 : 12754 9
21. Lerma E, Esteller M, Herman JG, Prat J. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol 2002 33 : 1120 5
22. Emerson RE, Ulbright TM, Eble JN, Geary WA, Eckert GJ, Cheng L. Predicting cancer progression in patients with penile squamous cell carcinoma: the importance of depth of invasion and vascular invasion. Mod Pathol 2001 14 : 963 8
23. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edn. New York : Springer, 2002 : 303 8
24. Nonogaki S, Wakamatsu A, Filho AL et al. Molecular strategies for identifying human papillomavirus infection in routinely processed samples: focus on paraffin sections. J Low Genit Tract Dis 2005 9 : 219 24
25. van der Brule A, Pol R, Fransen-Daalmeijer N, Schouls L, Meijer C, Snijders P. GP5+/6+ PCR followed by Reverse Line Blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002 40 : 779 87
26. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27
27. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999 59 : 793 7
28. Ioachim E, Michael MC, Salmas M et al. Thrombospondin-1 expression in urothelial carcinoma. Prognostic significance and association with p53 alterations, tumor angiogenesis and extracellular matrix components. BMC Cancer 2006 6 : 140 7
29. Lopes A, Bezerra AL, Pinto CA, Serrano SV, de Mello CA, Villa LL. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002 168 : 81 6
30. Vermeulen PB, Gasparini G, Fox SB et al. Quantification of angiogenesis of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996 32A : 2474 84
31. Rubin MA, Kleter B, Zhou M et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001 159 : 1211 8
32. Bezerra AL, Lopes A, Landman G, Alencar GN, Torloni H, Villa LL. Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol 2001 25 : 673 8
33. Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997 176 : 353 61
34. Chan KW, Lam KY, Chan AC, Lau P, Srivastava G. Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: a study of 41 cases using PCR. J Clin Pathol 1994 47 : 823 6
35. Nobeyama H, Sumi T, Misugi F et al. Association of HPV infection with prognosis after neoadjuvant chemotherapy in advanced uterine cervical cancer. Int J Mol Med 2004 14 : 101 5
36. Van der Avoort IA, Shirango H, Hoevenaars BM et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 2006 25 : 22 9
37. Lont AP, Kroon BK, Horenblas S et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 2006 119 : 1078 81
38. Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996 156 : 1637 42
39. Tringler B, Grimm C, Sliutz G et al. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma. Gynecol Oncol 2005 99 : 80 3
40. Kodama J, Hashimoto I, Seki N et al. Thrombospondin-1 and - 2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis. Clin Cancer Res 2001 7 : 2826 31
41. Karavasilis V, Malamou-Mitsi V, Briasoulis E et al. Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer 2005 5 : 25
42. Rice AJ, Steward MA, Quinn CM. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast. J Clin Pathol 2002 55 : 921 5
43. Wu MP, Tzeng CC, Wu LW, Huang KF, Chou CY. Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis. Cancer J 2004 10 : 27 32
44. Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 2003 9 : 3635 40
45. Neuhausen A, Florl AR, Grimm MO, Schulz WA. DNA methylation alterations in urothelial carcinoma. Cancer Biol Ther 2006 5 : 993 1001
46. Kuzmin I, Liu L, Dammann R et al. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res 2003 63 : 1888 93
47. Ferreux E, Lont AP, Horenblas S et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 2003 201 : 109 18
48. Nogueira MC, Guedes Neto Ede P, Rosa MW, Zettler E, Zettler CG. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 2006 12 : 153 7
49. Markowska J, Nowak M, Bar M, Harlozinska A. Expression of p53 and coexistence of HPV in premalignant lesions and in cervical cancer. Eur J Gynaecol Oncol 1995 16 : 368 72
50. Martins AC, Faria SM, Cologna AJ, Suaid HJ, Tucci S Jr. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002 167 : 89 92
51. Tokunaga T, Nakamura M, Oshika Y et al. Alterations in tumor suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells. Virchows Arch 1998 433 : 415 8